X
Translate:
Media Inquiries?
Please call

04/20/20

RUTGERS, UNIVERSITY HOSPITAL LEAD WAY IN TREATING COVID-19 WITH CONVALESCENT PLASMA FROM RECOVERED PATIENTS

Researchers, doctors call for more blood donations from former patients to help treat critically ill

Rutgers physicians and University Hospital are leading the way in using blood plasma from patients who recovered from COVID-19 to treat new patients who are severely ill with COVID-19 infections. The clinicians and hospital are calling for more blood donations from those who have survived the deadly infection.

Although COVID-19 infections and fatalities continue to increase in New Jersey and across the United States, more than 50,000 people have recovered from the novel virus. Their blood plasma
contains antibodies that may help critically ill patients fight, and perhaps conquer, the virus.

Last Friday, Rutgers practitioners at University Hospital received the first FDA approval for this treatment in New Jersey, and have thus far treated 17 patients with convalescent plasma. FDA
approval is pending for the use of this treatment for additional patients.

The effectiveness of this treatment is not yet known, though similar treatment has been studied for Ebola and the MERS virus. Practitioners and researchers will monitor and investigate the progress of COVID-19 patients who receive this treatment.

“The use of convalescent plasma – blood plasma from individuals who have recovered from COVID-19 – presents real hope for saving lives,” said Marc Klapholz, Chair of the Department of Medicine at Rutgers New Jersey Medical School and University Hospital, and the Principal Investigator for the use of Convalescent COVID-19 plasma.

“In our battle against the COVID-19 virus, we are excited to be trialing this potential life-saving therapy in partnership with Rutgers New Jersey Medical School. This treatment plan has been
used for more than 100 years to address disease outbreaks for other conditions, and we’re optimistic that it will save lives,” said Shereef Elnahal, President and CEO of University Hospital.

People interested in donating plasma must have had a confirmed positive test for COVID-19 from a lab or health facility and be eligible to donate blood. They can reach the Rutgers and
University Hospital COVID-19 Treatment Group at 973-972-5474 or via email at covidplasma@uhnj.org.

Other Recent News Stories
06/04/24

University Hospital Welcomes Dr. Paul J. Gaglio as Director of Liver Disease and Transplant Hepatology

UNIVERSITY HOSPITAL WELCOMES DR. PAUL J. GAGLIO AS DIRECTOR OF LIVER DISEASE AND TRANSPLANT HEPATOLOGY University Hospital is pleased to announce that Paul J. Gaglio, MD FACP, AGAF, FAASLD, has been named the Director of the Division of Liver Disease and Transplant Hepatology as well as the Medical Director of Liver Transplantation at University Hospital …

University Hospital Welcomes Dr. Paul J. Gaglio as Director of Liver Disease and Transplant Hepatology Read More »

More
01/17/24

FOR IMMEDIATE RELEASE       MEDIA CONTACT   January 17, 2024 media@uhnj.org, (973) 634-8298    UNIVERSITY HOSPITAL AND RUTGERS NEW JERSEY MEDICAL SCHOOL LAUNCH COMPREHENSIVE WEIGHT MANAGEMENT CENTER    Ribbon Cutting Unveils New Rutgers Weight Management Center at University Hospital      Newark, NJ— Today, University Hospital proudly launched a new multidisciplinary Weight Management Center in partnership …

Read More »

More
01/10/24

UNIVERSITY HOSPITAL WELCOMES NEW CHIEF COMPLIANCE AND PRIVACY OFFICER

UNIVERSITY HOSPITAL WELCOMES NEW CHIEF COMPLIANCE AND PRIVACY OFFICER NEWARK, NJ — University Hospital today announced the appointment of Astara Crews as its new Chief Compliance Officer. Astara will assume a crucial role in the hospital’s executive leadership team, overseeing compliance initiatives and contributing to the institution’s commitment to providing high-quality healthcare to the Newark …

UNIVERSITY HOSPITAL WELCOMES NEW CHIEF COMPLIANCE AND PRIVACY OFFICER Read More »

More
Scroll to Top